QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rollot, F. Articles by Blanche, P. Search for Related Content PubMed PubMed Citation Articles by Rollot, F. Articles by Blanche, P.

Acute Colchicine Intoxication During Clarithromycin Administration

Chief Resident, Internal Medicine, Cochin Hospital, Paris, France

Olivier Pajot, MD

Resident, Internal Medicine, Cochin Hospital

Laurence Chauvelot-Moachon, MD

Assistant, Pharmacovigilance Centre, Cochin-Saint Vincent de Paul Hospital, Paris

Eve M Nazal, MD

Resident, Internal Medicine, Cochin Hospital

Charikleia Kélaïdi, MD

Resident, Internal Medicine, Cochin Hospital

Philippe Blanche, MD

Assistant, Internal Medicine, Cochin Hospital

Reprints: Florence Rollot MD, Internal Medicine, Cochin Hospital, Paris 75014, France, fax 33 1 58 41 20 80, florence.rollot{at}cch.ap-hop-paris.fr

OBJECTIVE: To report a case of colchicine intoxication occurring with institution of clarithromycin.

CASE SUMMARY: A 76-year-old man with familial Mediterranean fever (FMF) had received colchicine 1.5 mg daily for 6 years. The patient underwent 7 days of clarithromycin, amoxicillin, and omeprazole treatment for Helicobacter pylori–associated gastritis. Fever, abdominal pain, and diarrhea occurred 3 days after treatment initiation. On day 8, dehydration, pancytopenia, metabolic acidosis, and increased lipase level necessitated hospitalization. Alopecia was observed 2 weeks later. The patient recovered fully after the colchicine dosage was reduced to 0.5 mg/day and rehydration was performed. The previous dosage was then reinstituted without adverse reaction. An objective causality assessment revealed that the adverse event was probable.

DISCUSSION: Continuous colchicine administration is used in treatment of microcrystalline arthritis, Behçet's disease, and FMF. Colchicine is primarily eliminated through biliary excretion. Renal elimination and cytochrome P450 metabolism play a less significant role. Colchicine is also a substrate of P-glycoprotein, a transporter involved in cellular efflux and elimination of numerous drugs. Three cases of intoxication have been reported when colchicine was combined with erythromycin, josamycin, or clarithromycin. Macrolides are inhibitors of P-glycoprotein and cytochrome P450–dependent enzymes and may decrease colchicine's biliary excretion through P-glycoprotein inhibition.

CONCLUSIONS: Coadministration of colchicine and macrolides may impair colchicine elimination, resulting in excess drug exposure and toxicity. To this end, colchicine should be used with extreme caution in patients receiving P-glycoprotein inhibitors, particularly if they are elderly and/or renally compromised.

Key Words: clarithromycin, colchicine, P-glycoprotein

Published Online, October 19, 2004. www.theannals.com, DOI 10.1345/aph.1E197

This article has been cited by other articles:

				M. Imazio, A. Brucato, R. Trinchero, D. Spodick, and Y. Adler Colchicine for pericarditis: hype or hope? Eur. Heart J., March 1, 2009; 30(5): 532 - 539. [Abstract] [Full Text] [PDF]

				T. Kallinich, D. Haffner, T. Niehues, K. Huss, E. Lainka, U. Neudorf, C. Schaefer, S. Stojanov, C. Timmann, R. Keitzer, et al. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement Pediatrics, February 1, 2007; 119(2): e474 - e483. [Abstract] [Full Text] [PDF]

				H. Zhou Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures? J. Clin. Pharmacol., November 1, 2006; 46(11): 1268 - 1289. [Abstract] [Full Text] [PDF]

				A. Brucato, Y. Adler, D. H. Spodick, M. Imazio, E. Cecchi, D. Demarie, B. Demichelis, F. Pomari, M. Moratti, G. Gaschino, et al. Letter Regarding Article by Imazio et al, "Colchicine in Addition to Conventional Therapy for Acute Pericarditis" * Response Circulation, April 11, 2006; 113(14): e693 - e694. [Full Text] [PDF]